Old Web
English
Sign In
Acemap
>
authorDetail
>
Kazuya Morimoto
Kazuya Morimoto
West Japan Railway Company
Medicine
Androgen
Oncology
Prostate cancer
Pathology
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Impact of enzalutamide and sequential flutamide and enzalutamide therapy for castration-resistant prostate cancer after bicalutamide-combined androgen blockade therapy onoverall survival: A follow-up study of randomized phase 2 trial (OCCU-CRPC study).
2019
Journal of Clinical Oncology
Taro Iguchi
Satoshi Tamada
Minoru Kato
Sayaka Yasuda
Taiyo Otoshi
Y. Machida
Tetsuji Ohmachi
Keiichi Ishii
Hiroyuki Iwata
Shinji Yamamoto
Tomohiro Kanamaru
Kazuya Morimoto
T. Hase
Koichiro Tashiro
Koji Harimoto
Takashi Deguchi
Takahisa Adachi
Katsuki Iwamoto
Yoshinori Takegaki
Tatsuya Nakatani
Show All
Source
Cite
Save
Citations (0)
Quantitative evaluation of age‐related changes to pelvic floor muscles in magnetic resonance images from 369 patients
2019
Geriatrics & Gerontology International
Yoshimitsu Komemushi
Atsushi Komemushi
Kazuya Morimoto
Yukio Yoneda
Rikio Yoshimura
Tomoaki Tanaka
Takeharu Katou
Tatsuya Nakatani
Show All
Source
Cite
Save
Citations (2)
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: A multicenter randomized phase II trial (OCUU-CRPC study).
2019
Journal of Clinical Oncology
Taro Iguchi
Satoshi Tamada
Minoru Kato
Sayaka Yasuda
Y. Machida
Tetsuji Ohmachi
Keiichi Ishii
Hiroyuki Iwata
Shinji Yamamoto
Tomohiro Kanamaru
Kazuya Morimoto
Taro Hase
Koichiro Tashiroro
Koji Harimoto
Takashi Deguhi
Takahisa Adachi
Katsuki Iwamoto
Yoshinori Takegaki
Tatsuya Nakatani
Show All
Source
Cite
Save
Citations (0)
1